A Study of RO5190591 (Danoprevir) in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1 Virus Infection

NCT00963885 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

229

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: Copegus
DRUG: Pegasys
DRUG: Placebo
DRUG: Placebo
DRUG: RO5190591 (Danoprevir)
DRUG: RO5190591 (Danoprevir)
DRUG: RO5190591 (Danoprevir)
DRUG: RO5190591 (Danoprevir)

Sponsor

Hoffmann-La Roche